PharmaResearch Co., Ltd. (214450.KQ)
KRW 259500.0
(2.77%)
KRW 259500.0
(2.77%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7502.00 KRW | 86.14% |
| 2022 | 4067.47 KRW | -13.76% |
| 2021 | 4716.62 KRW | 36.81% |
| 2020 | 3447.46 KRW | 95.21% |
| 2019 | 1766.04 KRW | 15.6% |
| 2018 | 1527.72 KRW | 10.2% |
| 2017 | 1386.28 KRW | -5.81% |
| 2016 | 1471.83 KRW | -12.78% |
| 2015 | 1687.48 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 3058.13 KRW | 80.9% |
| 2024 Q1 | 1690.49 KRW | 11.93% |
| 2023 Q4 | 1510.37 KRW | -43.54% |
| 2023 Q2 | 1664.31 KRW | -6.1% |
| 2023 Q1 | 1772.34 KRW | 370.58% |
| 2023 Q3 | 2675.04 KRW | 60.73% |
| 2023 FY | - KRW | 86.14% |
| 2022 Q1 | 933.84 KRW | -3.78% |
| 2022 FY | - KRW | -13.76% |
| 2022 Q4 | 376.63 KRW | -78.43% |
| 2022 Q2 | 1010.55 KRW | 8.21% |
| 2022 Q3 | 1746.44 KRW | 72.82% |
| 2021 Q1 | 1268.38 KRW | 33.75% |
| 2021 Q2 | 1149.46 KRW | -9.38% |
| 2021 Q3 | 1331.94 KRW | 15.88% |
| 2021 Q4 | 970.49 KRW | -27.14% |
| 2021 FY | - KRW | 36.81% |
| 2020 Q2 | 1044.58 KRW | 102.61% |
| 2020 Q3 | 806.92 KRW | -22.75% |
| 2020 Q4 | 948.35 KRW | 17.53% |
| 2020 FY | - KRW | 95.21% |
| 2020 Q1 | 515.56 KRW | 12.32% |
| 2019 Q2 | 359.03 KRW | -33.93% |
| 2019 FY | - KRW | 15.6% |
| 2019 Q4 | 459.01 KRW | 13.65% |
| 2019 Q3 | 403.88 KRW | 12.49% |
| 2019 Q1 | 543.37 KRW | -17.52% |
| 2018 FY | - KRW | 10.2% |
| 2018 Q4 | 658.81 KRW | 446.32% |
| 2018 Q3 | 120.59 KRW | -47.02% |
| 2018 Q1 | 445.70 KRW | 640.57% |
| 2018 Q2 | 227.62 KRW | -48.93% |
| 2017 Q3 | 574.00 KRW | 42.77% |
| 2017 Q2 | 402.04 KRW | -18.44% |
| 2017 Q1 | 492.96 KRW | 477.37% |
| 2017 FY | - KRW | -5.81% |
| 2017 Q4 | -82.45 KRW | -114.36% |
| 2016 Q4 | 85.38 KRW | -80.98% |
| 2016 Q1 | 438.59 KRW | 33.52% |
| 2016 FY | - KRW | -12.78% |
| 2016 Q3 | 449.00 KRW | -8.61% |
| 2016 Q2 | 491.32 KRW | 12.02% |
| 2015 FY | - KRW | 0.0% |
| 2015 Q4 | 328.48 KRW | -41.89% |
| 2015 Q3 | 565.25 KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Co., Ltd. | -1559.61 KRW | 581.018% |
| iNtRON Biotechnology, Inc. | -292.11 KRW | 2668.211% |
| BINEX Co., Ltd. | 151.04 KRW | -4866.896% |
| Bioneer Corporation | -410.19 KRW | 1928.909% |
| Anterogen.Co.,Ltd. | -291.93 KRW | 2669.794% |
| MEDIPOST Co., Ltd. | 287.00 KRW | -2513.937% |
| CrystalGenomics, Inc. | -661.00 KRW | 1234.947% |
| Helixmith Co., Ltd | -1543.76 KRW | 585.956% |
| Chabiotech Co.,Ltd. | -149.80 KRW | 5108.011% |
| Medy-Tox Inc. | 1456.65 KRW | -415.017% |
| Peptron, Inc. | -773.61 KRW | 1069.739% |
| Amicogen, Inc. | -583.58 KRW | 1385.514% |
| Genexine, Inc. | -1652.14 KRW | 554.078% |
| HLB Therapeutics Co.,Ltd. | -32.12 KRW | 23456.164% |
| LegoChem Biosciences, Inc. | -2595.00 KRW | 389.094% |
| ALTEOGEN Inc. | -65.27 KRW | 11593.795% |
| SillaJen, Inc. | -179.98 KRW | 4268.241% |
| JETEMA, Co., Ltd. | 783.21 KRW | -857.853% |
| OliX Pharmaceuticals,Inc | -1323.81 KRW | 666.698% |
| Genomictree Inc. | -391.00 KRW | 2018.67% |
| MedPacto, Inc. | -1664.87 KRW | 550.606% |
| D&D Pharmatech | 409.19 KRW | -1733.378% |
| EASY BIO,Inc. | 455.00 KRW | -1548.791% |
| GI Innovation, Inc. | -1285.69 KRW | 683.5% |